Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiotics in Prevention of NEC in Preterm Babies
NCT07233382Active, not recruiting
- Sponsor
- Hayatabad Medical Complex
- Start
- Apr 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Randomised trial of probiotic oral spray in necrotizing enterocolitis (NEC) (2 arms), sponsored by Hayatabad Medical Complex. Primary endpoint: Incidence of Necrotizing Enterocolitis at 30 days. Started Apr 2026; status: active, not recruiting.
02
Drugs
probiotic oral spray
03
Conditions
necrotizing enterocolitis (NEC)
Beyond the preview
Go deeper on NCT07233382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07233382.